Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.


GREY:ALEAF - Post by User

Comment by ShakngMyHead00on Apr 30, 2021 10:13pm
35 Views
Post# 33107139

RE:RE:RE:RE:RE:RE:RE:RE:RE:17.7 Net, 7.2 miilion adjusted ebhida

RE:RE:RE:RE:RE:RE:RE:RE:RE:17.7 Net, 7.2 miilion adjusted ebhida
ShakngMyHead00 wrote:
Toweringmars wrote: Could it be possible that they sold some biomass in the previous quarter? The company didnt report it in the actual harvest numbers this year, though we know in years past that WMD and NRTH reported biomass numbers for their total yeild. Geoff was very clear that the 31,200kgs was flower. That might account for the lower wholesale price.

stocktracker101 wrote:
Here it is right from their MD&A document

Quarterly Financial Highlights q4 MD&A
 
Three months ended Year ended  Dec 31, 2020 
 
Cannabis net revenue $14,121,000
 
Net medical cannabis revenue $2,717,000 ÷ 7.97 = 340.9 kg
Net adult-use cannabis revenue $1,409,000 ÷ 4.61 = 323.2 kg
Net bulk wholesale cannabis revenue $9,995,000 ÷ 0.48 = 20,790.16 kgs.

Average net selling price per gram 
of medical cannabis(1) $7.97 
Average net selling price per gram 
of adult-use cannabis(1) $4.61
Average net selling price per gram 
of bulk wholesale cannabis(1) $0.48 
 
Kilograms sold 21,368 
 
KEY DEVELOPMENTS DURING Q4 2020
2020 Outdoor Grow Results
On November 6, 2020, the Company reported its Port Perry Facility’s outdoor cannabis harvest results, 
where 50,000 plants yielded approximately 31,200 kgs of dried cannabis flower at a cash cost per gram
to harvest of $0.10. Included in the total yield is 7,200 kgs of THC-dominant dried flower, much of 
which is used to accelerate the expansion of the Company's adult-use product portfolio. 

It's all there in black and white. Nothing to wait and see.

stocktracker101 wrote: Look at kg sold in their q4 md&a. I go by earnings not press releases. Deduct that from their entire harvest and multiply by $0.48/gram. That was the average sale price of bulk flower in q4. You are suggesting $6 million bulk sales q1.. That would require 12,000kgs or 12 million grams @ .48/gram (q4s avg sale price per gram). They grew total 31,000 kg + outdoor. Minus 21,000 kg already sold in q4 (as per q4 md&a), = 10,000kg. Even if they sold the outdoor flower put aside for prerolls that's only $5 million in bulk sales. And we know 7,000 kgs was put aside for prerolls. They have apprx 4,000kgs left of bulk deducting the 7,000kgs for prerolls. My figures are all from q4 financials and q4 md&a. There is no way they have 6 million from outdoor in q1. The only way is if they sold indoor bulk to Europe.
sthinei wrote: Huh? How do you figure $2 million outdoor wholesale even they said in november that they had already contracted $16 million in sales from outdoor grow op with majority in q4. That would leave 6 million for q1 plus any incremental sales. I am also hoping they are receiving slightly better pricing on the remaining contracts. Maybe that would be optimistic. "16M in Contracted Cannabis Sales: In addition to growth in the medical, adultuse and international channels, the Company has contracted sales that will, upon completion of shipments, generate net revenue of $16 million. It is expected that the majority of the domestic wholesale shipments will be completed in the three months ended December 31, 2020 (Q4 2020), with the remainder shipping to customers early in the first quarter of 2021 (Q1 2021).

 








<< Previous
Bullboard Posts
Next >>